Tuesday, 27 October 20264:37 am ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

India

‘No basis for concerns over SMA generic drug,’ says technical panel chief

Image: Onmanorama. Rights remain with the publisher.

Kerala plans to procure Natco's legally approved generic spinal muscular atrophy drug, costing eight thousand rupees instead of five lakh twenty thousand, saving millions annually despite political row and safety objections.

Read the full report on Onmanorama

Story file

Section
India
Places
Kerala
First reported by
Onmanorama
Reporter
manoj kadambad
Published
Sunday, 25 October 2026, 1:22 pm IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Onmanorama with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More India news

See all